Hospital Puerta del Mar

Cadiz 11009

0 studies enrolling now · 9 studies all time

What they study most

Atrial Fibrillation, Diamond Blackfan Anemia, Early Breast Cancer, Idiopathic Pulmonary Fibrosis, Lung Diseases, Interstitial, Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Myelofibrosis, Pain, Psoriasis, Sickle Cell Disease, Thalassemia

Studies at this site

• A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis — Running, not enrolling
• A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) — Running, not enrolling
• Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation — Completed
• A Study to Investigate Leramistat in Patients With IPF — Withdrawn before enrolling
• Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis — Completed
• Real-World Outcomes Study on Subjects Treated With Radiofrequency Ablation — Completed
• Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) — Completed
• Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload — Completed